Ed Arce

Stock Analyst at HC Wainwright & Co.

(0.68)
# 1839
Out of 5,240 analysts
553
Total ratings
37.71%
Success rate
5.02%
Average return
57 Stocks
Name Action Price Target Current % Upside Ratings Updated
Travere Therapeutics
Maintains: Strong Buy
18 22
17.05 29.03% 20 Jan 15, 2025
Akebia Therapeutics
Reiterates: Buy
8 8
1.9 294.74% 33 Jan 14, 2025
NewAmsterdam Pharma
Reiterates: Buy
48 48
23.77 101.94% 2 Jan 14, 2025
Madrigal Pharmaceuti...
Maintains: Strong Buy
390 400
274.16 45.9% 16 Jan 14, 2025
Arcturus Therapeutic...
Reiterates: Buy
63 63
16.48 282.28% 27 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
0.7 1614.29% 16 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 4
0.66 506.06% 24 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
1.98 506.06% 1 Dec 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 16 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
95 95
40.11 136.85% 4 Dec 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 18
4.86 270.37% 10 Dec 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8 8
4.58 63.76% 11 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
21.85 128.83% 22 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.19 56.74% 17 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
4.12 676.7% 9 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
66 66
43.33 52.32% 29 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24 24
20.86 15.05% 21 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 29
6.28 361.78% 20 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6
5.61 -1.96% 7 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38 38
11.24 238.08% 20 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75 75
30.01 149.92% 4 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 13
2.11 516.11% 13 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
3.45 276.81% 17 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.6 212.5% 13 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
7.53 72.64% 16 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
0.58 934.48% 4 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
12 240
1.5 15900% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 8 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
33
n/a n/a 20 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
34.59 -27.72% 8 Dec 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 8 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
3
n/a n/a 12 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
40
n/a n/a 4 Jun 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 5 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
42
n/a n/a 10 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 69
n/a n/a 1 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6 2
n/a n/a 4 Mar 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 39
n/a n/a 8 Nov 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13500 14625
1.9 769636.84% 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1750 0
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 12, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
2188
1.79 122106.7% 4 May 31, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 15
n/a n/a 3 Mar 22, 2019